Industry Satellite Symposia
Switch To Module
ESMO Congress 2021 - Conference Calendar
On-demand Educational sessions
On-demand Special Symposia
On-demand Multidisciplinary sessions
On-demand ePosters
Industry Satellite Symposia
Digital Evaluations
Everything
Everything
Session Title
Session Number
Presentation Title
Presentation Number
Author
Presenter
Chair
Filter By
Day
Select All
Deselect All
Fri, 17.09.2021
12
Sat, 18.09.2021
11
Sun, 19.09.2021
12
Mon, 20.09.2021
11
Tue, 21.09.2021
11
Room
Select All
Deselect All
Channel 3
14
Channel 4
15
Channel 5
13
Channel 6
15
Session Type
Select All
Deselect All
Industry Satellite Symposium
57
Presentation Type
Select All
Deselect All
Invited Speaker
57
Presentation Topic
Select All
Deselect All
General interest
57
Cancel
Clear
Search
Advanced Search
Sign in
Scheduled sessions
On-demand Educational sessions
On-demand Special Symposia
On-demand Multidisciplinary sessions
On-demand ePosters
Industry Satellite Symposia
Final Programme PDF
Browsing Over 57 Sessions
Sort By
Session Number
Upcoming First
Relevance
Session Number
Session Datetime
Bristol Myers Squibb - Shaping Tomorrow Today: What Does the Future Hold for Melanoma?
(ID 146)
Time
08:45 - 10:05
MSD - The Role of Biomarkers in Patient Management in Immuno-Oncology
(ID 103)
Time
10:30 - 11:30
Advanced Accelerator Applications, a Novartis Company - Cutting through the noise: How do GEP-NET patients stand to benefit from PRRT?
(ID 137)
Time
08:45 - 10:15
Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
(ID 127)
Time
10:30 - 12:00
Pfizer Oncology - Complex Management of Relapsed and Refractory Multiple Myeloma (RRMM) and Evaluation of Unmet Needs
(ID 117)
Time
10:30 - 12:00
Mirati Therapeutics, Inc. - Rapid Progress During a Pandemic: Emerging Therapeutic Options for NSCLC
(ID 152)
Time
10:30 - 12:00
Bayer - Taking action in nmCRPC: Cases in the clinic
(ID 108)
Time
18:45 - 20:15
AstraZeneca - Mapping pathways for PARP inhibition in prostate cancer: practical considerations for clinical practice
(ID 142)
Time
18:45 - 20:15
MSD - Homologous Recombination Deficiency: BRCA and beyond
(ID 99)
Time
08:45 - 09:50
Boehringer Ingelheim - CTRL + ALT + DEL: Disrupting Cancer’s Operating Functions
(ID 132)
Time
18:45 - 20:15
Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
(ID 123)
Time
08:45 - 09:55
Bristol Myers Squibb - Immuno-oncology for GI Cancers: A Clinical Lens on Current Data
(ID 157)
Time
17:35 - 19:05